Recombinant Human Secretogranin-2 Protein，His

Secretogranin-2 (SgII), a member of the secretogranin family, is a protein predominantly expressed in neuroendocrine tissues. It plays a significant role in the packaging and secretion of neuropeptides and hormones, influencing various physiological processes, including neurodevelopment, hormone regulation, and neurotransmission. Studies have indicated that SgII may be involved in the pathophysiology of several conditions, such as neurodegenerative diseases and certain cancers, making it a potential biomarker for early diagnosis and therapeutic targets. The recombinant production of SgII has garnered attention, as it allows for the exploration of its functional properties in controlled experimental settings. By expressing and purifying this protein, researchers can investigate its structural characteristics, interactome, and biological activities, providing deeper insights into its role in health and disease. Furthermore, recombinant SgII can serve as a valuable tool for the development of diagnostic assays and therapeutic interventions. Understanding the molecular mechanisms governed by SgII may ultimately contribute to advancing treatment strategies for neuroendocrine disorders and enhancing the comprehension of neuropeptide functions within various biological contexts. Hence, the study of SgII through recombinant protein research is vital for unveiling its biological significance and potential clinical implications.